Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

MicroRNA-181a reduces proliferation and migration induced by E2/NET by suppressing PGRMC1: a novel option to reduce breast cancer risk during MHT?

Created on 17 Nov 2026

Authors

Yuejiao Wang, Xiangyan Ruan, Muqing Gu, Yun Wei, Yuwei Guan, Alfred O Mueck

Published in

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology. Volume 42. Issue 1. Pages 2760011. Dec 31, 2026. Epub Nov 16, 2026.

Abstract

Clinical studies suggest that estradiol combined with norethisterone (E2/NET) may increase breast cancer risk, and PGRMC1 plays a crucial function in this process. According to previous research, we demonstrated that E2/NET stimulated the proliferation of PGRMC1-overexpressing breast cancer (BC) cells. This in vitro study aimed to investigate the mechanism of microRNA-181a's anti-tumor effects on PGRMC1-overexpressing BC cells treated with E2/NET.
Stable PGRMC1-overexpressing MCF7 and T47D breast cancer cell models were established to analyze cell viability, cell proliferation, colony formation, and cell migration, to characterize miR-181a's anti-tumor effects on BC cells with E2/NET exposure. qRT-PCR and Western blot were performed to measure the expression of PGRMC1, PGRMC2, G3BP2, Pairbp1, NF-kB, and BAX at gene and protein levels. Luciferase reporter assays were performed to evaluate miR-181a binding to 3'UTR of PGRMC2 and G3BP2.
Overexpression of miR-181a significantly reduced PGRMC1-overexpressing MCF7 cell viability, proliferation, and migration. Substantially decreased gene expression of PGRMC1, PGRMC2, G3BP2, Pairbp1, and NF-kB, and increased BAX in miR-181a-treated cells. MiR-181a inhibited PGRMC1 signaling through directly targeting PGRMC2 and G3BP2 and upregulating pro-apoptotic BAX.
We reported evidence that miR-181a reduces the PGRMC1-overexpressing cell viability and upregulates pro-apoptotic BAX expression. MiR-181a can inhibit E2 combined with NET-induced PGRMC1, PGRMC2, and G3BP2 complex, thereby reducing the proliferation and migration effect of breast cancer cells treated with E2/NET.

PMID:
43038099
Bibliographic data and abstract were imported from PubMed on 17 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 7
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement